SymBiosis

SymBiosis is a venture capital firm investing in U.S. biotechnology and life sciences companies, with a focus on therapeutics including biologics, cell therapy, genetic medicine and small-molecule approaches across oncology, immunology, infectious disease, neurology and cardiometabolic disease. The firm backs early- and later-stage venture rounds and has acted as a co-lead investor, making it relevant for therapeutics companies raising Series A through growth-stage venture capital.